Cefcapene (INN) is a third-generation cephalosporin antibiotic.
It was patented in 1985 and approved for medical use in 1997 in Japan, where it is sold under the Tradename Flomox by Shionogi & Co., Ltd. It is also approved and available as a generic in South Korea and China. It is known to cause severe hypocarnitinemia and associated serious hypoglycaemia, seizures, and encephalopathy in children.
References